Funded Tech Companies

Cortexyme

Headquartered in South San Francisco, Cortexyme raised its funding from Pfizer Venture Investments, Verily and Takeda Ventures.

Company Overview

Company Name
Cortexyme
Company Status
Publicly-held
Funding Rounds

Contact Information

Mailing Address
269 East Grand Ave.
South San Francisco, CA 94080
USA
Email Address

Company Background Information

Overview
Cortexyme (Nasdaq: CRTX) is developing treatments for Alzheimer's and other degenerative disorders.
Profile
Cortexyme LinkedIn Company Profile
Social Media
Cortexyme Company Twitter Account
Company News
Cortexyme News
Facebook
Cortexyme on Facebook
YouTube
Cortexyme on YouTube
Last Transaction
5/8/2019

Financing History

Date
Type
Amount
IPO
$74,800,000
Venture Equity
$76,000,000
Debt
$7,600,000
Venture Equity
$7,918,642
Venture Equity
$1,000,000
Venture Equity
$350,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Casey Lynch
  Casey  Lynch LinkedIn Profile  Casey  Lynch Twitter Account  Casey  Lynch News  Casey  Lynch on Facebook
Chief Scientific Officer
Stephen Dominy
  Stephen Dominy LinkedIn Profile  Stephen Dominy Twitter Account  Stephen Dominy News  Stephen Dominy on Facebook
Executive Vice President
Leslie Holsinger
  Leslie Holsinger LinkedIn Profile  Leslie Holsinger Twitter Account  Leslie Holsinger News  Leslie Holsinger on Facebook
VP - Operations
Kristen Gafric
  Kristen Gafric LinkedIn Profile  Kristen Gafric Twitter Account  Kristen Gafric News  Kristen Gafric on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Cortex.io | Corthera

 

Share this article

 


About Our VC Transaction Database

This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary